SCHEMBL2889067

SCHEMBL2889067

[CH2]C=CC#CCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5133037 1.00
SCHEMBL2010084 0.78
SCHEMBL6487194 0.75
SCHEMBL31344998 0.73
SCHEMBL830189 0.71
SCHEMBL972050 0.69
SCHEMBL263643 0.69
SCHEMBL9249993 0.67
SCHEMBL13692730 0.67
SCHEMBL10807871 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1578757-B1 FLUOROGENIC ENZYME SUBSTRATES AND METHODS OF PREPARATION JANSSEN INFECTIOUS DISEASES BVBA (BE) 2014-10-22 EP disclosed
US-7863428-B2 Fluorogenic enzyme substrates and methods of preparation TIBOTEC BVBA (BE) 2011-01-04 US disclosed
US-7652008-B2 2,2,7,9-tetramethyl-4-[(2-phenylethyl)amino]-3,4-dihydro-2H-pyrano[2,3-g]quinolin-3-ol; 3-hydroxy-2,2,9-trimethyl-4-[(2-phenylethyl)amino]-3,4-dihydro-2H-pyrano[2,3-g]quinolin-7-carbonitrile; have the prolongation effect on refractory period NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2010-01-26 US disclosed
US-20070037234-A1 fluorophores containing 2-(3H-4-oxo-6-n-pentyl-2-quinazolinyl)-4-n-pentylphenyl phosphate; hydrolases; improved cell permeability; photostability TIBOTEC BVBA (BE) 2007-02-15 US disclosed
EP-1578757-A2 FLUOROGENIC ENZYME SUBSTRATES AND METHODS OF PREPARATION Tibotec BVBA (BE) 2005-09-28 EP disclosed
WO-2004058787-A2 FLUOROGENIC ENZYME SUBSTRATES AND METHODS OF PREPARATION TIBOTEC BVBA (BE) 2004-07-15 WO disclosed
US-5444084-A Anticholesterol, antilipidemic agents BANYU PHARMACEUTICAL CO., LTD. (JP) 1995-08-22 US disclosed
EP-0609448-A1 SUBSTITUTED HETEROCYCLIC DERIVATIVE HAVING SQUALENE EPOXIDASE INHIBITORY EFFECT AND USE THEREOF BANYU PHARMACEUTICAL CO., LTD. (JP) 1994-08-10 EP disclosed